HomeCompareFLXI vs PFE

FLXI vs PFE: Dividend Comparison 2026

FLXI yields 0.43% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $31.3K in total portfolio value· pulled ahead in Year 8
10 years
FLXI
FLXI
● Live price
0.43%
Share price
$48.27
Annual div
$0.21
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.04
Full FLXI calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — FLXI vs PFE

📍 PFE pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLXIPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLXI + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLXI pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLXI
Annual income on $10K today (after 15% tax)
$36.44/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $23,128.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLXI + PFE for your $10,000?

FLXI: 50%PFE: 50%
100% PFE50/50100% FLXI
Portfolio after 10yr
$35.4K
Annual income
$13,605.29/yr
Blended yield
38.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

FLXI
No analyst data
Altman Z
31.0
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLXI buys
0
PFE buys
0
No recent congressional trades found for FLXI or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLXIPFE
Forward yield0.43%6.20%
Annual dividend / share$0.21$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$19.7K$51.1K
Annual income after 10y$0.04$27,210.54
Total dividends collected$43.00$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLXI vs PFE ($10,000, DRIP)

YearFLXI PortfolioFLXI Income/yrPFE PortfolioPFE Income/yrGap
1$10,721$21.43$9,161$701.38+$1.6KFLXI
2$11,483$10.74$8,610$859.79+$2.9KFLXI
3$12,292$5.37$8,366$1,081.25+$3.9KFLXI
4$13,155$2.69$8,483$1,405.66+$4.7KFLXI
5$14,077$1.34$9,084$1,907.24+$5.0KFLXI
6$15,063$0.67$10,418$2,732.78+$4.6KFLXI
7$16,118$0.34$13,007$4,193.56+$3.1KFLXI
8← crossover$17,246$0.17$18,010$7,005.87$764.00PFE
9$18,454$0.08$28,216$12,979.89$9.8KPFE
10$19,746$0.04$51,081$27,210.54$31.3KPFE

FLXI vs PFE: Complete Analysis 2026

FLXIStock

FlexiInternational Software Inc. develops, markets, and supports back office accounting software solutions for companies in banking and credit union, insurance, financial services, and other service industries worldwide. The company offers offers FlexiFinancials suite that consists of FlexiLedger, a core repository of financial transactions; FlexiPayables, an accounts payable module; FlexiPurchasing to track and streamline the purchasing processes; FlexiAssets, a fixed assets module; FlexiProjects that manages, tracks, and analyzes project costs, budgets, encumbrances, and status; FlexiFDW, an event-driven data repository; and FlexiReceivables for companies to manage and track their receivables. It also provides FlexiTools applications to customize FlexiFinancials, such as FlexiDesigner to customize the FlexiFinancials Suite GUI using an interactive visual design editor; and FlexiDB that allows the customization of the Flexi database structures. In addition, the company offers FlexiInfo Suite that consist of FlexiWorkflow, an application that is integrated with various FlexiFinancial modules; FlexiImaging that provides integration with various third party imaging solutions, including Microsoft SharePoint; and RenovoFYI, a Web based financial report writer. Further, it provides FlexiIntegration suite that consists of FlexiAPIs that provide real-time, synchronous access to functional components within the FlexiFinancials Suite of applications; FlexiNetExchange to provide a seamless integration with Jack Henry's Silverlake core banking solution, Synergy Workflow, and Synergy Imaging; and FlexiImport/Export Wizard that allow users to import and export data. Furthermore, the company offers consulting, training and education, and support services. It has strategic partnerships with Acturis; and Jack Henry & Associates. The company was founded in 1991 and is based in Shelton, Connecticut with additional locations in Naples, Florida; and Surrey, United Kingdom.

Full FLXI Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this FLXI vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLXI vs SCHDFLXI vs JEPIFLXI vs OFLXI vs KOFLXI vs MAINFLXI vs JNJFLXI vs MRKFLXI vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.